Carman2, not unexpected. That is the problem when management has eroded trust in the brand. It takes a long time and strong results when you are digging out of a brand equity hole. 

It's always better to launch from a feeling of trust and strength. If we get good results on the science and it points to revenue generation in a reasonable time frame I think Eversana will be able to provide visibility and credibility to apabetalone and the RVX brand.

Still good news to get this started.

GLTA

Toinv